Prosecution Insights
Last updated: April 19, 2026

Excellgene SA

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17383109 METHODS OF PRODUCING AND USING RECOMBINANT ALPHA 1-ANTITRYPSIN (AAT) AND COMPOSITIONS THEREOF EDWARDS, JESSICA FAYE 1657 Final Rejection Jul 22, 2021

Managing Excellgene SA's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month